Our Mission
Our mission is to revolutionize point-of-care diagnostics with our unique technology, making accurate and rapid testing accessible to all. Increasing access will ensure a safer workplace for employees & employers, as well as advance our healthcare industry.
We are the creator of the XALIVA® rapid diagnostics platform that provides high-quality, cost-effective, and rapid results for employers using only a small amount of saliva. The testing platform leverages the first truly portable nanoparticle detection technology, allowing for fast, non-invasive point-of-care diagnostics.
With the collaboration of industry experts, the company’s platform is versatile and expanding into new point-of-care diagnostics beyond drug testing, such as infectious disease, maternal health, and cancer detection applications.
Our Team
HIMANSHU BHATIA, M.D.
FOUNDER & CEO
20+ years experience in Research, Development, and Commercialization of medical devices.
MD, MS (Biochemistry), and MBA.
PIYUSH SADANA
CO-FOUNDER & COO
Serial entrepreneur with 20+ years of experience in Investment Banking & Hi-Tech.
MBA, Columbia Business School.
JOSEPH SEIMETZ, Ph.D.
DIRECTOR OF R&D
GAUTAM BATRA
CTO
15+ years of product development experience from concept to mass production in consumer electronics, payments technologies and automotive industry.
MS (Electrical Engineering), University of Texas – Arlington.
BRETT FELMEY
VP OF SALES & HR
20+ years of experience in B2B sales with Fortune 500 companies.
PRATIK PATEL
CMO
20+ years commercializing over 50 health-tech products to market.
BA and MA (Neuroscience, Biomedical Science) and PLD-14 (Management) from Harvard Business School.
JO MCGUIRE
ADVISOR
Executive Director, NDASA (National Drug & Alcohol Screening Association) with more than 10 years of experience in the drug and alcohol testing industry.
DET. ANDREW REDFIELD
ADVISOR – LAW ENFORCEMENT
10+ years of Law Enforcement experience Drug Recognition Expert (DRE).
Advisory Board
SURYA MOHAPATRA
35+ yrs of leadership experience in Healthcare Industry.
Former President & CEO of Quest Diagnostics.
Board Member of Xylem Inc, Leidos Inc, and Malaria No More.
BEN BALDANZA
Former CEO of Spirit Airlines.
Board Member of JetBlue Airlines.
Operating Partner at Sterling Investments.
CARRA WALLACE
The first Chief Diversity Officer appointed by New York City Comptroller.
Founder of Optimized Diversity Solutions, a strategic advisory firm delivering disruptive solutions that increase the utilization of Minority- and Women-Owned Businesses (MWBEs).
